Lack of genetic evidence for a role of SLC25A46 in alpha-synucleinopathies

<i>SLC25A46</i> variants showed no evidence of association, suggesting the gene does not play a major role in PD, RBD, or DLB risk.

Authors

Institutions

Publication Details

Journal
medRxiv
Published
2026-02-01
DOI
https://doi.org/10.64898/2026.01.30.26344974
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Lack of genetic evidence for a role of SLC25A46 in alpha-synucleinopathies

Zhao Zhang, Meron Teferra, Jamil Ahmad, Farnaz Asayesh et al.
medRxiv
Parkinson's Disease Mechanisms and Treatments
article

Lack of genetic evidence for a role of SLC25A46 in alpha-synucleinopathies

Zhao Zhang, Meron Teferra, Jamil Ahmad, Farnaz Asayesh, Han Yu, Guy Rouleau, Emma Somerville, Sitki Cem Parlar, Lang Liu, Ziv Gan-Or, Konstantin Senkevich
article en

Abstract

<i>SLC25A46</i> variants showed no evidence of association, suggesting the gene does not play a major role in PD, RBD, or DLB risk.

medRxiv
Montreal Neurological Institute and Hospital (CA), Quantitative BioSciences (US), McGill University (CA)
Partnerships for the goals
Openalex Percentile: Top 71%
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.